Vaginal health: a woman’s right!
Nappi Rossella E.
Two clinical trials previously demonstrated the safety of 300 mcg/day transdermal testosterone patch (TTP) treatment for up to 6 months in 1094 surgically menopausal women with hypoactive sexual desire disorder (HSDD). Adverse events (AE), clinical laboratory tests, vital signs, physical examinations, and mammograms were evaluated in open-label extensions of these two trials for up to 4 years and are presented in this paper. more
Objective: To assess the prevalence and the relative importance of risk factors for low bone mass in Indian pre and postmenopausal women. Methods: Data were collected on anthropometry and lifestyle factors in apparently healthy 80 pre- and 92 postmenopausal (40-75 yr) women. Bone mineral density was measured by dual energy x-ray absorptiometry. Fasting blood samples were analyzed for Parathyroid hormone, Vitamin D, calcium and zinc. more